IDEX Stock Price, News & Analysis

IDEX Corporation (NYSE:IEX) has scheduled its fourth quarter earnings conference call for February 1, 2023, at 9:30 a.m. CT. CEO Eric Ashleman and CFO William Grogan will discuss the company’s financial performance for Q4 and the full year 2022, followed by a Q&A session. Interested investors can listen live and view presentation slides on the company’s website. An archive of the call will be available afterward, with an audio replay accessible until March 1, 2023.

IDEX Corporation (NYSE:IEX) has completed the acquisition of Muon B.V., a micro-precision technology manufacturer based in the Netherlands. Muon specializes in creating precise flow paths for various industries, including medical technologies and semiconductor manufacturing. IDEX believes this acquisition aligns well with their mission-critical solutions and organizational values. The Muon Group will be integrated into IDEX's Health & Science Technology segment, providing new growth opportunities and synergies in precision-engineering applications.

IDEX Corporation (NYSE:IEX) has announced a quarterly cash dividend of $0.60 per common share, set to be paid on January 27, 2023, to shareholders of record as of January 13, 2023. This marks the company's 113th consecutive quarterly cash dividend payment. IDEX operates over 45 businesses globally, reporting nearly $2.8 billion in annual sales and employing more than 8,000 staff across more than 20 countries.

IDEX Corporation (NYSE: IEX) reported strong financial results for Q3 2022, featuring a record EPS of $2.36, up 56% year-over-year, and record sales of $824 million, a 16% increase. The company's operating margins improved, with a reported margin of 24.5%. Cash from operations reached $198 million, representing 111% of net income. IDEX also announced the acquisition of Muon Group for €700 million, aimed at bolstering its growth strategy. For 2022, the company raised its EPS guidance to $7.75-$7.80, expecting a 12% organic sales growth for the full year.

IDEX Corporation (NYSE:IEX) will host its third quarter earnings conference call on October 26, 2022, at 9:30 a.m. CT. CEO Eric Ashleman and CFO William Grogan will present the financial results and answer questions from investors. The call will be accessible via their website. An audio replay of the conference will be available until November 26, 2022. IDEX has nearly $2.8 billion in sales, operates over 45 businesses, and employs more than 8,000 people globally.

IDEX Corporation (NYSE: IEX) announced the appointment of Katrina L. Helmkamp as Non-Executive Chair of its Board of Directors, effective October 1, 2022. Helmkamp has been an independent director since November 2015 and has extensive global business experience, formerly serving as CEO of Lenox Corporation and as President and CEO of Cartus Corporation. She succeeds William M. Cook, who is retiring after 14 years. The Board's size will decrease from 11 to 10 directors.

IDEX Corporation (NYSE:IEX) has declared a regular quarterly cash dividend of $0.60 per common share, set for payment on October 28, 2022. Shareholders of record as of October 14, 2022 will receive this dividend, marking the company's 112th consecutive quarterly payout. With nearly $2.8 billion in annual sales and a global presence across more than 20 countries, IDEX continues to provide mission-critical components that enhance everyday life.

IDEX Corporation (NYSE:IEX) has entered into a definitive agreement to acquire Muon B.V. for €700 million. Muon Group specializes in micro-precision manufacturing for critical applications in various industries, including medical technology and semiconductor sectors. With projected FY 2022 sales of approximately €140 million and EBITDA margins around 33%, this acquisition aims to enhance IDEX’s precision technology platform and expand synergies within its health and science segment. The deal is anticipated to close in Q4, pending regulatory approvals.

IDEX Corporation (NYSE: IEX) reported a strong second quarter 2022, with EPS rising 35% to $1.81 and a record adjusted EPS of $2.02, up 15% versus Q2 2021. Orders reached $839 million, reflecting a 12% overall increase, while sales grew 16% to $796 million. Operating margin improved to 23.4%. The company raised its full-year EPS guidance to $7.19-$7.29 (GAAP) and $7.88-$7.98 (adjusted). Notably, IDEX successfully completed the acquisition of KZValve, enhancing its agricultural product portfolio.